Meeting the worldwide challenge of drug resistant tuberculosis with Deeplex®Myc-TB 

Innovations from sample through analysis for Mycobacterium tuberculosis identification and drug resistance prediction

19 November 2019 

8 am PT | 11 pm ET | 5 pm CET


Agathe Jouet, PhD 

Research Engineer GenoScreen


Pierre Bourbon, PhD 

Head of Solutions Development BlueBee

In this webinar, you will learn about how the Deeplex®Myc-TB kit, with complete analysis, provides insights for samples with Mycobacterium tuberculosis.

Key learnings include

  • Current state of the global drug resistant tuberculosis
  • Targeted sequencing with Deeplex
  • Streamlined workflow from raw data through analysis
  • Data compliance regulations
  • On-demand access to computational resources and storage for any scale 
  • Secure sharing of data with collaborators


© BlueBee